Halozyme Therapeutics Inc (HALO)

[friendofthedevil]

That was a nice call then. Clearly, I would like for you to be right on this also. And I do think HALO will have better numbers for us than ASCO, else they wouldn't likely be presenting. As we know, the study isn't blinded and the almost have to have a good idea of what they will see with this look.

Sorry Fritz for being obtuse. I am finding it difficult to find time this week to post. I was rushed last night. All I meant to say was that the minimum qualification for a poster to be accepted is only to have new data. This requirement could be filled with an up date (ie: more mature data) that produced the same or even worse OS and TE numbers than before. The conference doesn't care what the results show. Only we do.